Injeck Pharma SRL
Injeck Pharma reported total assets of 185,431 € at the end of the 2025 financial year (annual accounts filed with the NBB on 13 May 2026).
The score of Injeck Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -18 % Total assets +117 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Injeck Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 59,891 € | ||||
| Equity | 20,094 € | ||||
| Cash | 39,656 € | ||||
| EBITDA | 99,690 € | ||||
| Total assets | 185,431 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 13 May 2026
- Year ended 31 Dec 2024filed on 25 Jul 2025
- Year ended 31 Dec 2023filed on 26 Aug 2024
- Year ended 31 Dec 2022filed on 25 Jul 2023
- Year ended 31 Dec 2021filed on 25 Aug 2022
Injeck Pharma's financial analysis
- Solvency10.8%sector median: 50.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Injeck Pharma
Injeck Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0689.594.279
- VAT number
- BE0689594279
- Peppol
- Registered · 0208:0689594279 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 31 Jan 2018
- Registered office
- 1300 Wavre
- Latest accounts
- 2025 · filed on 13 May 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Injeck Pharma (SRL) has been based in Wavre since 2018, active in: business and other management consultancy activities. For 2025, it reports a net profit of 59,891 € and equity of 20,094 €; its revenue is not published. Its solvency stands at 10.8%, below the median of its sector (50.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Injeck Pharma
Companies in the same business, of comparable size and area, outside its group.
- Cekoja Partners Business and other management consultancy activities Maaseik · balance sheet 133,711 €
- Atrium Management Support Business and other management consultancy activities Nijlen · balance sheet 214,246 €
- MVS-Invest Business and other management consultancy activities Kapellen · balance sheet 671,917 €
- SD Project & Management Business and other management consultancy activities Walhain · balance sheet 386 €
- LCH Consulting Business and other management consultancy activities Walcourt · balance sheet 109,286 €
- Nutmeg Business and other management consultancy activities Deinze · balance sheet 185,840 €
- Domaro Business and other management consultancy activities Ittre · balance sheet 187,106 €
- LMO Management Business and other management consultancy activities Wanze · balance sheet 6,604 €
Frequently asked questions about Injeck Pharma
What is the revenue of Injeck Pharma?
Injeck Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Injeck Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0689594279 for Injeck Pharma, if the company is VAT-registered. Its company number (CBE) is 0689.594.279.
Where is the registered office of Injeck Pharma?
According to the CBE register, the registered office of Injeck Pharma is in 1300 Wavre.
What is the equity of Injeck Pharma?
At the close of the 2025 financial year, the equity of Injeck Pharma amounts to 20,094 €, a solvency of 10.8% of total assets.
Who manages Injeck Pharma?
The register lists 1 active mandates at Injeck Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Injeck Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →